Docetaxel maintenance therapy versus best supportive care after first-line chemotherapy with different dose docetaxel plus cisplatin for advanced non-small cell lung cancer (TFINE study, CTONG-0904): an open-label, randomized, phase III trial

BACKGROUND: Maintenance therapy is important in the management of advanced non-small cell lung cancer (NSCLC). The present TFINE study assessed the efficacy and safety of docetaxel continuation maintenance (DCM) therapy after first-line treatment with different doses of docetaxel plus cisplatin. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li, Lu, Shun, Cheng, Ying, Hu, Zhihuang, Wu, Yi-Long, Chen, Zhiwei, Chen, Gongyan, Liu, Xiaoqing, Yang, Jinji, Chen, Jia, Huang, Meijuan, Tao, Min, Cheng, Gang, Huang, Cheng, Zhou, Caicun, Zhang, Weimin, Zhao, Hong, Sun, Yuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944306/
https://www.ncbi.nlm.nih.gov/pubmed/33708965
http://dx.doi.org/10.21037/atm-20-8078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944306/
https://www.ncbi.nlm.nih.gov/pubmed/33708965
http://dx.doi.org/10.21037/atm-20-8078

Ejemplares similares